Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Score 2
2008 pubmed 20 citations

Antimicrobial effects of H4-(86-100), histogranin and related compounds--possible involvement of DNA gyrase.

Lemaire. Simon S; Trinh. Thuy-Tiên TT; Le. Hoang-Thanh HT; Tang. Shun-Chii SC; Hincke. Maxwell M; Wellman-Labadie. Olivier O; Ziai. Sophie S

Key Findings

  • H4-(86-100) and HNr inhibit growth of both gram‑negative and gram‑positive bacteria with potency similar to LL‑37
  • Full‑length peptides are much more effective than shorter fragments or precursors
  • Their antibacterial action involves inhibition of DNA gyrase and is enhanced by ATP, while metabolic poisons block the effect

Practical Outcomes

  • At this stage the peptides are not available as a consumer product, so there’s no direct protocol to follow. The findings hint that future antimicrobial or gut‑health supplements could be built around these peptides, but more research and safety testing are needed before biohackers can use them.

Summary

Researchers found that two naturally occurring peptides, H4-(86-100) and histogranin (HNr), can kill a range of bacteria as well as the well‑studied antimicrobial peptide LL‑37. They work by blocking a bacterial enzyme called DNA gyrase, and their killing power is boosted by ATP but stopped by metabolic toxins. The study was done in test‑tube experiments, not in people, so it’s not yet a usable supplement or treatment.

Abstract

Histone-derived antimicrobial peptides have been identified in various organisms from plants to humans. The rat histone H4 mRNA variants, H4-v.1 and rat histogranin (HNr) mRNAs, were recently reported to be involved in the synthesis of H4-(86-100) and its related peptide HNr, respectively. Herein, the two peptides were investigated for putative antimicrobial activity and found to inhibit growth of gram-negative (Escherichia coli, Pseudomonas aeruginosa) and gram-positive (Bacillus subtilis, Staphylococcus aureus) bacteria. Their inhibitory potencies in E. coli (LD(50): 3.48 and 4.34 microg x mL(-1)) are comparable to that of the antimicrobial peptide LL-37 (LD(50): 4.10 microg x mL(-1)). The antimicrobial activities of H4-(86-100) and HNr depend upon the integrity of the molecules, as precursors [H4-(84-102), pro-HNr] and fragments [bovine histogranin (HNb)-(1-13), HNb-(3-13), H4-(89-102) or OGP] are at least five times less potent than the parent peptides. Among various HN-like compounds, cyclo-(-Gly-pCl-Phe-Tyr-D-Arg) (compound 3) and N-5-guanidino pentanamide-(2R)-yl-2-N-(p-hydroxyphenylacetyl)-4-(p-chlorobenzoyl)-phenylene diamine (compound 8) display antimicrobial activities comparable to that of HNr. Interestingly, the antimicrobial activities of H4-(86-100), HNr and compound 3, like those of quinolone antibiotics acting as DNA gyrase poisons, are potentiated by ATP (1 mM) and coumermycin A1 (a DNA gyrase-linked ATPase inhibitor) and blocked by 2,4-dinitrophenol (DNP, an uncoupler of oxidative phosphorylation) and fluoroacetic acid (a metabolic poison). Finally, in vitro experiments indicate that H4-(86-100), HNr, compound 3 and compound 8, but not HNb-(1-13) or HNb-(3-13), inhibit DNA gyrase-mediated supercoiling of pBR322 DNA. These data indicate that the naturally occurring H4-(86-100) and HNr display antimicrobial effects that involve a modulation of ATP-dependent DNA gyrase.

Study Information

Provider

pubmed

Year

2008

Date

2008-09-18T00:00:00.000Z

DOI

10.1111/j.1742-4658.2008.06659.x

Citations

20

References

40